Physiological Profile and Limitations in Exercise in Idiopathic Pulmonary Fibrosis

被引:8
|
作者
Vainshelboim, Baruch [1 ,2 ]
Oliveira, Jose [2 ]
Fox, Benjamin Daniel [1 ,3 ]
Adir, Yochai [4 ]
Ollech, Jacob Eliezer [1 ]
Kramer, Mordechai Reuven [1 ,3 ]
机构
[1] Beilinson Med Ctr, Pulm Inst, Rabin Med Ctr, IL-49100 Petah Tiqwa, Israel
[2] Univ Porto, Res Ctr Phys Act Hlth & Leisure CIAFEL, Fac Sport, Oporto, Portugal
[3] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[4] Technion Israel Inst Technol, Lady Davis Carmel Med Ctr, Fac Med, Div Pulm, Haifa, Israel
关键词
aerobic exercise capacity; cardiopulmonary exercise test; functional capacity; idiopathic pulmonary fibrosis; 6-minute walk test; INTERSTITIAL LUNG-DISEASE; 6-MINUTE WALK; REHABILITATION; CAPACITY; STANDARDIZATION; RECOMMENDATIONS; GUIDELINES; STATEMENT; DIAGNOSIS; MORTALITY;
D O I
10.1097/HCR.0000000000000177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: This study aimed to describe the physiological profile and limiting factors during exercise among patients with idiopathic pulmonary fibrosis. METHODS: A descriptive study involving 34 patients with idiopathic pulmonary fibrosis (22 men) aged 68 +/- 8 years was conducted. All patients completed a pulmonary function test, cardiopulmonary exercise test, Doppler echocardiography, 6-minute walk test, and modified Medical Research Council dyspnea evaluation. RESULTS: Approximately 38% of patients (range, 15%-71%) presented with coexisting comorbidities including pulmonary hypertension and emphysema. Modified Medical Research Council grades 0-2 and 3-4 were assigned to 68% and 32% of patients, respectively. Median values for forced vital capacity and diffusion capacity for carbon monoxide percent (%) predicted were 68 (95% CI, 63-76) and 51 (95% CI, 46-55), respectively. Left ventricular systolic function was normal. Aerobic capacity ((V)Over dotO(2peak) = 13.4 mL/kg/min [95% CI, 12.6-14.9]; 62% predicted [95% CI, 56-67]) was moderately reduced with the presence of abnormalities in pulmonary gas exchange and desaturation, circulatory impairments, inefficient ventilation, and skeletal muscle dysfunction. Functional capacity was normal (6-minute walk test distance = 505 m [95% CI, 435-522]; 99% predicted [95% CI, 91-108]). CONCLUSIONS: The physiological profile demonstrated the presence of comorbidities in approximately 38% of patients with idiopathic pulmonary fibrosis and a moderate level of dyspnea. Resting cardiopulmonary function showed moderate pulmonary restriction and severe impairments in diffusion capacity with normal left ventricular systolic function. Multifactorial limitations for a moderately diminished aerobic capacity were revealed during the cardiopulmonary exercise test, although functional capacity was normal. These results emphasize the significance of a meticulous evaluation, including the cardiopulmonary exercise test for an accurate exercise tolerance evaluation, to aid in the diagnosis and prognosis and for developing effective targeted treatments.
引用
收藏
页码:270 / 278
页数:9
相关论文
共 50 条
  • [1] Exercise training in idiopathic pulmonary fibrosis
    Vainshelboim, Baruch
    Fox, Benjamin Daniel
    Oliveira, Jose
    Kramer, Mordechai Reuven
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (01) : 69 - 77
  • [2] Physiological Responses and Prognostic Value of Common Exercise Testing Modalities in Idiopathic Pulmonary Fibrosis
    Vainshelboim, Baruch
    Myers, Jonathan
    Oliveira, Jose
    Izhakian, Shimon
    Unterman, Avraham
    Kramer, Mordechai Reuven
    [J]. JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2019, 39 (03) : 193 - 198
  • [3] Expression profile of phosphodiesterases in idiopathic pulmonary fibrosis
    Nikolova, S
    Pullamsetti, S
    Ghofrani, H
    Weissmann, N
    Seeger, W
    Grimminger, F
    Schermuly, R
    [J]. MEDIZINISCHE KLINIK, 2006, 101 (04) : A84 - A84
  • [4] Physiological Response to Exercise and Vital Prognosis in Patients with Combined Pulmonary Fibrosis and Emphysema: Comparison to Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
    Boily-Daoust, C.
    Chalaoui, J.
    Poirier, C.
    Morisset, J.
    Dube, B.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [5] Exercise training in idiopathic pulmonary fibrosis: is it of benefit?
    Vainshelboim, Baruch
    [J]. BREATHE, 2016, 12 (02) : 131 - 138
  • [6] Exercise capacity in idiopathic pulmonary fibrosis: The effect of pulmonary hypertension
    Boutou, Afroditi K.
    Pitsiou, Georgia G.
    Trigonis, Ioannis
    Papakosta, Despina
    Kontou, Paschalina K.
    Chavouzis, Nikolaos
    Nakou, Chrysanthi
    Argyropoulou, Paraskevi
    Wasserman, Karlman
    Stanopoulos, Ioannis
    [J]. RESPIROLOGY, 2011, 16 (03) : 451 - 458
  • [7] Pulmonary vascular limitation to exercise and survival in idiopathic pulmonary fibrosis
    van der Plas, Mart N.
    van Kan, Coen
    Blumenthal, Judith
    Jansen, Henk M.
    Wells, Athol U.
    Bresser, Paul
    [J]. RESPIROLOGY, 2014, 19 (02) : 269 - 275
  • [8] Sex differences in physiological progression of idiopathic pulmonary fibrosis
    Han, M. K.
    Murray, S.
    Fell, C. D.
    Flaherty, K. R.
    Toews, G. B.
    Myers, J.
    Colby, T. V.
    Travis, W. D.
    Kazerooni, E. A.
    Gross, B. H.
    Martinez, F. J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (06) : 1183 - 1188
  • [9] PERIPHERAL BLOOD IMMUNOLOGICAL PROFILE OF IDIOPATHIC PULMONARY FIBROSIS
    Mendoza Barco, N.
    Casas-Recasens, S.
    Hernandez, F.
    Cruz, T.
    Albacar, N.
    Lopez-Saiz, G.
    Alzina, X.
    Agusti, A.
    Sellares, J.
    Faner, R.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [10] Pirfenidone tablets in idiopathic pulmonary fibrosis: a profile of their use
    Lyseng-Williamson K.A.
    [J]. Drugs & Therapy Perspectives, 2018, 34 (1) : 8 - 15